In the case of astrocytomas, the mutated IDH reduces alpha-ketoglutarate to D2-hydroxyglutarate, an oncometabolite that accumulates in the targeted tissue [39]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).